These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18401209)

  • 1. Clinical and biochemical improvement in acromegaly during pregnancy.
    Lau SL; McGrath S; Evain-Brion D; Smith R
    J Endocrinol Invest; 2008 Mar; 31(3):255-61. PubMed ID: 18401209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acromegaly and pregnancy].
    Bétéa D; Valdes Socin H; Hansen I; Stevenaert A; Beckers A
    Ann Endocrinol (Paris); 2002 Oct; 63(5):457-63. PubMed ID: 12442089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 diabetes associated with asymptomatic acromegaly successfully treated with surgery after pregnancy: a case report.
    Iwai H; Ito H; Ri S; Harada T; Hirota N; Yamauchi T; Miyatake T; Ohno Y; Aoki N
    Endocr J; 2005 Aug; 52(4):413-20. PubMed ID: 16127208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery.
    Okada Y; Morimoto I; Ejima K; Yoshida K; Kashimura M; Fujihira T; Eto S
    Endocr J; 1997 Feb; 44(1):117-20. PubMed ID: 9152623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly and pregnancy.
    Caron P
    Ann Endocrinol (Paris); 2011 Sep; 72(4):282-286. PubMed ID: 21820101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
    Abe T; Lüdecke DK
    Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
    Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
    Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a two-year treatment with slow release lanreotide in acromegaly.
    Cannavò S; Squadrito S; Curtò L; Almoto B; Vieni A; Trimarchi F
    Horm Metab Res; 2000 Jun; 32(6):224-9. PubMed ID: 10898551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.
    Beckers A; Stevenaert A; Foidart JM; Hennen G; Frankenne F
    J Clin Endocrinol Metab; 1990 Sep; 71(3):725-31. PubMed ID: 2118540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatment.
    Shimon I; Nass D; Hadani M
    Pituitary; 2000 May; 2(4):289-94. PubMed ID: 11081151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of acromegaly in pregnant woman].
    Ben Salem Hachmi L; Kammoun I; Bouzid C; Smida H; Nagi S; Turki Z; Ben Slama C
    Ann Endocrinol (Paris); 2010 Feb; 71(1):60-3. PubMed ID: 19926070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
    Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegaly.
    Martín-Rodríguez JF; Madrazo-Atutxa A; Venegas-Moreno E; Benito-López P; Gálvez MÁ; Cano DA; Tinahones FJ; Torres-Vela E; Soto-Moreno A; Leal-Cerro A
    PLoS One; 2013; 8(4):e60041. PubMed ID: 23593161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.